Jackson Wealth Management LLC Sells 128 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Jackson Wealth Management LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 549 shares of the healthcare conglomerate’s stock after selling 128 shares during the quarter. Jackson Wealth Management LLC’s holdings in UnitedHealth Group were worth $288,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter valued at $30,000. Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $40,000. Finally, Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the fourth quarter valued at $41,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.4%

NYSE UNH opened at $308.69 on Friday. The stock’s 50 day moving average is $324.99 and its 200 day moving average is $447.32. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a market cap of $280.03 billion, a PE ratio of 12.93, a P/E/G ratio of 1.48 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the firm posted $6.91 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Insiders Place Their Bets

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director owned 6,033 shares of the company’s stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. Robert W. Baird lowered UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Finally, Raymond James Financial downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.